These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 1644854
21. The role of topical vitamin D modulators in psoriasis therapy. Tanghetti EA. J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s4-8. PubMed ID: 19702030 [Abstract] [Full Text] [Related]
22. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy. Abramovits W. J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032 [Abstract] [Full Text] [Related]
23. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Murdoch D, Clissold SP. Drugs; 1992 Mar; 43(3):415-29. PubMed ID: 1374321 [Abstract] [Full Text] [Related]
24. Defects in the synthesis and metabolism of vitamin D. Holick MF. Exp Clin Endocrinol Diabetes; 1995 Mar; 103(4):219-27. PubMed ID: 7584527 [Abstract] [Full Text] [Related]
25. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM. Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905 [Abstract] [Full Text] [Related]
26. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone. Augustin M, Peeters P, Radtke M, Moehling U, Lapp C. Dermatology; 2007 Jun; 215(3):219-28. PubMed ID: 17823519 [Abstract] [Full Text] [Related]
30. [New treatment of psoriasis with the vitamin D analogue calcipotriol]. Austad J. Tidsskr Nor Laegeforen; 1993 Nov 30; 113(29):3580-1. PubMed ID: 8273098 [Abstract] [Full Text] [Related]
34. Calcipotriol: a new drug for topical psoriasis treatment. Kragballe K. Pharmacol Toxicol; 1995 Oct 30; 77(4):241-6. PubMed ID: 8577633 [Abstract] [Full Text] [Related]
35. [Evaluation of topical calcipotriol in psoriasis]. Welsh-Lozano O, Gómez-de Garza M, Jaramillo-Moreńo G, González-González SE, Morales-Monsiváis MA. Gac Med Mex; 1996 Oct 30; 132(5):471-4. PubMed ID: 9011512 [Abstract] [Full Text] [Related]
36. Vitamin D analogues and psoriasis. Berth-Jones J, Hutchinson PE. Br J Dermatol; 1992 Aug 30; 127(2):71-8. PubMed ID: 1390159 [Abstract] [Full Text] [Related]
37. Topical calcipotriol in the treatment of intertriginous psoriasis. Kienbaum S, Lehmann P, Ruzicka T. Br J Dermatol; 1996 Oct 30; 135(4):647-50. PubMed ID: 8915166 [Abstract] [Full Text] [Related]
38. Management of psoriasis with calcipotriol used as monotherapy. Ramsay CA. J Am Acad Dermatol; 1997 Sep 30; 37(3 Pt 2):S53-4. PubMed ID: 9344185 [Abstract] [Full Text] [Related]
39. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM. J Dermatolog Treat; 2007 Sep 30; 18(1):32-9. PubMed ID: 17365265 [Abstract] [Full Text] [Related]